Literature DB >> 4102260

Differential effects of 6-mercaptopurine and cyclophosphamide on autoimmune phenomena in NZB mice.

E Lemmel, E R Hurd, M Ziff.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1971        PMID： 4102260      PMCID： PMC1712938     

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN： 0009-9104            Impact factor:   4.330


× No keyword cloud information.
  12 in total

1.  THE NATURAL HISTORY OF AUTOIMMUNE DISEASE IN NZB MICE. A COMPARISON WITH THE PATTERN OF HUMAN AUTOIMMUNE MANIFESTATIONS.

Authors:  M C HOLMES; F M BURNET
Journal:  Ann Intern Med       Date:  1963-09       Impact factor: 25.391

2.  Initiation of immune responses by small lymphocytes.

Authors:  J L GOWANS; D D McGREGOR; D M COWEN
Journal:  Nature       Date:  1962-11-17       Impact factor: 49.962

3.  Spontaneous auto-immune disease in NZB/BL mice.

Authors:  B J HELYER; J B HOWIE
Journal:  Br J Haematol       Date:  1963-04       Impact factor: 6.998

4.  Immunological function of thymus and bursa of Fabricius. Thymus lesions in an auto-immune disease of mice.

Authors:  F M BURNET; M C HOLMES
Journal:  Nature       Date:  1962-04-14       Impact factor: 49.962

5.  Immunosuppression by cyclophosphamide in NZB X NZW mice with lupus nephritis.

Authors:  T P Casey
Journal:  Blood       Date:  1968-09       Impact factor: 22.113

6.  Cyclophosphamide treatment of mouse systemic lupus erythematosus.

Authors:  R E Horowitz; E L Dubois; J Weiner; L Strain
Journal:  Lab Invest       Date:  1969-09       Impact factor: 5.662

Review 7.  Autoimmune and immunoproliferative diseases of NZB/Bl mice and hybrids.

Authors:  R C Mellors
Journal:  Int Rev Exp Pathol       Date:  1966

8.  A deficient development of the thymic epithelium and auto-immune disease in NZB mice.

Authors:  M J de Vries; W Hijmans
Journal:  J Pathol Bacteriol       Date:  1966-04

9.  Immunopathology of NZB/BL mice. V. Viruslike (filtrable) agent separable from lymphoma cells and identifiable by electron microscopy.

Authors:  R C Mellors; C Y Huang
Journal:  J Exp Med       Date:  1966-12-01       Impact factor: 14.307

10.  The carriage of immunological memory by small lymphocytes in the rat.

Authors:  J L Gowans; J W Uhr
Journal:  J Exp Med       Date:  1966-11-01       Impact factor: 14.307
View more
  9 in total

1.  Therapeutic effect of beta-[1-phenyl-5-bis(beta-chloroethyl)-amino-benzimidazolyl-(2)-DL-alanin (ZIMET 3164) on immune complex nephritis of NZB hybrid mice.

Authors:  J Güttner
Journal:  Agents Actions       Date:  1979-12

2.  Studies on thymus products. IV. Absence of serum 'thymic activity' in adult NZB and (NZB x NZW) F1 mice.

Authors:  J F Bach; M Dardenne; J C Salomon
Journal:  Clin Exp Immunol       Date:  1973-06       Impact factor: 4.330

3.  Immunoresponsiveness of patients with rheumatoid arthritis receiving cyclophosphamide or gold salts.

Authors:  J S Strong; B A Bartholomew; C J Smyth
Journal:  Ann Rheum Dis       Date:  1973-05       Impact factor: 19.103

4.  Treatment of S.L.E. nephritis.

Authors: 
Journal:  Br Med J       Date:  1973-05-19

5.  The mechanism of action of cyclophosphamide on the nephritis of (NZB x NZW)F1 hybrid mice.

Authors:  E R Hurd; M Ziff
Journal:  Clin Exp Immunol       Date:  1977-07       Impact factor: 4.330

6.  Effects of cytotoxic immunosuppressants on tuberculin-sensitive lymphocytes in guinea pigs.

Authors:  A Winkelstein
Journal:  J Clin Invest       Date:  1975-12       Impact factor: 14.808

7.  The differential effects of cyclophosphamide and 6-mercaptopurine on the renal disease and skin immunoglobulin deposits of the NZB-NZW F1 hybrid mice.

Authors:  E R Hurd; J N Gilliam; M Ziff
Journal:  Agents Actions       Date:  1976-02

8.  Intermittent cyclophosphamide in pemphigus vulgaris and bullous pemphigoid.

Authors:  A Medved; I Maxwell
Journal:  Can Med Assoc J       Date:  1974-08-03       Impact factor: 8.262

9.  Differential effects of immunosuppressants on lymphocyte function.

Authors:  A Winkelstein
Journal:  J Clin Invest       Date:  1973-09       Impact factor: 14.808
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.